Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease (EMPA-PKD)

NCT06391450 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Autosomal Dominant Polycystic Kidney

Interventions

DRUG: Empagliflozin 10 MG
DRUG: Placebo

Sponsor

Hannover Medical School

Collaborators

[object Object]